Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Effectiveness of eslicarbazepine acetate in dependency of baseline anticonvulsant therapy: Results from a German prospective multicenter clinical practice study.

Weissinger F, Losch F, Winter Y, Brecht S, Lendemans D, Kockelmann E.

Epilepsy Behav. 2019 Dec;101(Pt A):106574. doi: 10.1016/j.yebeh.2019.106574. Epub 2019 Oct 31.

PMID:
31678808
2.

Functional status and life satisfaction of patients with stable angina pectoris in Austria.

Spinka F, Aichinger J, Wallner E, Brecht S, Rabold T, Metzler B, Zweiker R, Lang I, Delle Karth G.

BMJ Open. 2019 Sep 4;9(9):e029661. doi: 10.1136/bmjopen-2019-029661.

3.

Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT).

Brecht S, Boda-Heggemann J, Budjan J, Siebenlist K, Stieler F, Steil V, Wenz F, Lohr F, Buergy D.

Radiother Oncol. 2019 May;134:166-177. doi: 10.1016/j.radonc.2019.02.003. Epub 2019 Feb 18.

PMID:
31005211
4.

DNA-dependent protein kinase (DNA-PK) permits vascular smooth muscle cell proliferation through phosphorylation of the orphan nuclear receptor NOR1.

Medunjanin S, Daniel JM, Weinert S, Dutzmann J, Burgbacher F, Brecht S, Bruemmer D, Kähne T, Naumann M, Sedding DG, Zuschratter W, Braun-Dullaeus RC.

Cardiovasc Res. 2015 Jun 1;106(3):488-97. doi: 10.1093/cvr/cvv126. Epub 2015 Apr 7.

PMID:
25852083
5.

Suicidal thoughts and reasons for living in hospitalized patients with severe depression: post-hoc analyses of a double-blind randomized trial of duloxetine.

Demyttenaere K, Desaiah D, Raskin J, Cairns V, Brecht S.

Prim Care Companion CNS Disord. 2014;16(3). pii: PCC.13m01591. doi: 10.4088/PCC.13m01591. Epub 2014 May 1.

6.

Incomplete tumour control following DNA vaccination against rat gliomas expressing a model antigen.

Ginzkey C, Eicker S, Marget M, Krause J, Brecht S, Westphal M, Hugo HH, Mehdorn M, Steinmann J, Hamel W.

Acta Neurochir (Wien). 2013 Jan;155(1):51-8; discussion 59. doi: 10.1007/s00701-012-1526-7. Epub 2012 Nov 8.

7.

Neuronal c-Jun is required for successful axonal regeneration, but the effects of phosphorylation of its N-terminus are moderate.

Ruff CA, Staak N, Patodia S, Kaswich M, Rocha-Ferreira E, Da Costa C, Brecht S, Makwana M, Fontana X, Hristova M, Rumajogee P, Galiano M, Bohatschek M, Herdegen T, Behrens A, Raivich G.

J Neurochem. 2012 May;121(4):607-18. doi: 10.1111/j.1471-4159.2012.07706.x. Epub 2012 Mar 21.

8.

Time course of improvement of different symptom clusters in patients with major depression and pain treated with duloxetine or placebo.

Demyttenaere K, Desaiah D, Petit C, Croenlein J, Brecht S.

Curr Med Res Opin. 2012 Jan;28(1):41-8. doi: 10.1185/03007995.2011.645561. Epub 2011 Dec 22.

PMID:
22126422
9.

Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis.

Crucitti A, Zhang Q, Nilsson M, Brecht S, Yang CR, Wernicke J.

Curr Med Res Opin. 2010 Nov;26(11):2579-88. doi: 10.1185/03007991003769241. Epub 2010 Sep 27.

PMID:
20874076
10.

Efficacy and safety of duloxetine 60 mg and 120 mg daily in patients hospitalized for severe depression: a double-blind randomized trial.

Brecht S, Desaiah D, Marechal ES, Santini AM, Podhorna J, Guelfi JD.

J Clin Psychiatry. 2011 Aug;72(8):1086-94. doi: 10.4088/JCP.09m05723blu. Epub 2010 Sep 21.

PMID:
20868642
11.

Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model.

Ginzkey C, Eicker SO, Marget M, Krause J, Brecht S, Westphal M, Hugo HH, Mehdorn HM, Steinmann J, Hamel W.

Cancer Immunol Immunother. 2010 Apr;59(4):541-51. doi: 10.1007/s00262-009-0771-y. Epub 2009 Oct 2.

PMID:
19798500
12.

FK506 protects against various immune responses and secondary degeneration following cerebral ischemia.

Brecht S, Waetzig V, Hidding U, Hanisch UK, Walther M, Herdegen T, Neiss WF.

Anat Rec (Hoboken). 2009 Dec;292(12):1993-2001. doi: 10.1002/ar.20994.

13.

Patient-assessed versus physician-assessed disease severity and outcome in patients with nonspecific pain associated with major depressive disorder.

Demyttenaere K, Desaiah D, Petit C, Croenlein J, Brecht S.

Prim Care Companion J Clin Psychiatry. 2009;11(1):8-15.

14.

Clinical impact of duloxetine treatment on sleep in patients with major depressive disorder.

Brecht S, Kajdasz D, Ball S, Thase ME.

Int Clin Psychopharmacol. 2008 Nov;23(6):317-24. doi: 10.1097/YIC.0b013e328306a987.

PMID:
18854719
15.

Predictors of relapse in a study of duloxetine treatment in patients with major depressive disorder.

Fava M, Wiltse C, Walker D, Brecht S, Chen A, Perahia D.

J Affect Disord. 2009 Mar;113(3):263-71. doi: 10.1016/j.jad.2008.05.023. Epub 2008 Jul 14.

PMID:
18625521
16.

Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.

Brecht S, Courtecuisse C, Debieuvre C, Croenlein J, Desaiah D, Raskin J, Petit C, Demyttenaere K.

J Clin Psychiatry. 2007 Nov;68(11):1707-16.

PMID:
18052564
17.

Serum anticholinergic activity in patients following cardiac surgery and healthy individuals following amitriptyline application.

Brecht S, Reiff J, Vock U, Voget J, Ley L, Boning A, Cremer J, Aldenhoff J, Herdegen T.

Methods Find Exp Clin Pharmacol. 2007 Apr;29(3):223-30.

PMID:
17520106
18.

Enhanced contractility of small blood vessels in JNK knockout mice.

Laukeviciene A, Brecht S, Kevelaitis E, Herdegen T.

Eur J Pharm Sci. 2006 Dec;29(5):335-9. Epub 2006 Jul 6.

PMID:
16949803
19.

Induction of immediate early gene expression by high-frequency stimulation of the subthalamic nucleus in rats.

Schulte T, Brecht S, Herdegen T, Illert M, Mehdorn HM, Hamel W.

Neuroscience. 2006;138(4):1377-85. Epub 2006 Feb 7.

PMID:
16460881
20.

Tumor necrosis factor-alpha receptor 1 (p55) knockout only transiently decreases the activation of c-Jun and does not affect the survival of axotomized dopaminergic nigral neurons.

Wessig J, Brecht S, Claussen M, Roemer L, Goetz M, Bigini P, Schutze S, Herdegen T.

Eur J Neurosci. 2005 Jul;22(1):267-72.

PMID:
16029216
21.

c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia.

Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, Goetz M, Lucius R, Herdegen T, Hanisch UK.

Glia. 2005 May;50(3):235-46.

PMID:
15739188
22.

Specific pathophysiological functions of JNK isoforms in the brain.

Brecht S, Kirchhof R, Chromik A, Willesen M, Nicolaus T, Raivich G, Wessig J, Waetzig V, Goetz M, Claussen M, Pearse D, Kuan CY, Vaudano E, Behrens A, Wagner E, Flavell RA, Davis RJ, Herdegen T.

Eur J Neurosci. 2005 Jan;21(2):363-77.

PMID:
15673436
23.

Therapeutic window for use of hyperbaric oxygenation in focal transient ischemia in rats.

Lou M, Eschenfelder CC, Herdegen T, Brecht S, Deuschl G.

Stroke. 2004 Feb;35(2):578-83. Epub 2004 Jan 8.

PMID:
14715976
24.

Mice deficient for the ets transcription factor elk-1 show normal immune responses and mildly impaired neuronal gene activation.

Cesari F, Brecht S, Vintersten K, Vuong LG, Hofmann M, Klingel K, Schnorr JJ, Arsenian S, Schild H, Herdegen T, Wiebel FF, Nordheim A.

Mol Cell Biol. 2004 Jan;24(1):294-305.

25.

Changes in peptidyl-prolyl cis/trans isomerase activity and FK506 binding protein expression following neuroprotection by FK506 in the ischemic rat brain.

Brecht S, Schwarze K, Waetzig V, Christner C, Heiland S, Fischer G, Sartor K, Herdegen T.

Neuroscience. 2003;120(4):1037-48.

PMID:
12927209
26.

Lithium blocks the c-Jun stress response and protects neurons via its action on glycogen synthase kinase 3.

Hongisto V, Smeds N, Brecht S, Herdegen T, Courtney MJ, Coffey ET.

Mol Cell Biol. 2003 Sep;23(17):6027-36.

27.

Differential effects of immunophilin-ligands (FK506 and V-10,367) on survival and regeneration of rat retinal ganglion cells in vitro and after optic nerve crush in vivo.

Rosenstiel P, Schramm P, Isenmann S, Brecht S, Eickmeier C, Bürger E, Herdegen T, Sievers J, Lucius R.

J Neurotrauma. 2003 Mar;20(3):297-307.

PMID:
12820684
28.

Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death.

Xu J, Culman J, Blume A, Brecht S, Gohlke P.

Stroke. 2003 May;34(5):1287-92. Epub 2003 Apr 3.

PMID:
12677021
29.

The c-Jun N-terminal kinases in cerebral microglia: immunological functions in the brain.

Hidding U, Mielke K, Waetzig V, Brecht S, Hanisch U, Behrens A, Wagner E, Herdegen T.

Biochem Pharmacol. 2002 Sep;64(5-6):781-8.

PMID:
12213570
30.
31.
32.

Caspase-3 activation and DNA fragmentation in primary hippocampal neurons following glutamate excitotoxicity.

Brecht S, Gelderblom M, Srinivasan A, Mielke K, Dityateva G, Herdegen T.

Brain Res Mol Brain Res. 2001 Oct 19;94(1-2):25-34.

PMID:
11597762
33.

Identification and characterization of an escorter for two secretory adhesins in Toxoplasma gondii.

Reiss M, Viebig N, Brecht S, Fourmaux MN, Soete M, Di Cristina M, Dubremetz JF, Soldati D.

J Cell Biol. 2001 Feb 5;152(3):563-78.

34.

The toxoplasma micronemal protein MIC4 is an adhesin composed of six conserved apple domains.

Brecht S, Carruthers VB, Ferguson DJ, Giddings OK, Wang G, Jakle U, Harper JM, Sibley LD, Soldati D.

J Biol Chem. 2001 Feb 9;276(6):4119-27. Epub 2000 Oct 26.

35.
36.

Genome engineering of Toxoplasma gondii using the site-specific recombinase Cre.

Brecht S, Erdhart H, Soete M, Soldati D.

Gene. 1999 Jul 8;234(2):239-47.

PMID:
10395896
38.

Repetitive electroconvulsive seizures induce activity of c-Jun N-terminal kinase and compartment-specific desensitization of c-Jun phosphorylation in the rat brain.

Brecht S, Simler S, Vergnes M, Mielke K, Marescaux C, Herdegen T.

Brain Res Mol Brain Res. 1999 May 7;68(1-2):101-8.

PMID:
10320787
39.

Rapid and long-lasting suppression of the ATF-2 transcription factor is a common response to neuronal injury.

Martin-Villalba A, Winter C, Brecht S, Buschmann T, Zimmermann M, Herdegen T.

Brain Res Mol Brain Res. 1998 Nov 20;62(2):158-66.

PMID:
9813301
40.

Persisting expression of galanin in axotomized mamillary and septal neurons of adult rats labeled for c-Jun and NADPH-diaphorase.

Brecht S, Buschmann T, Grimm S, Zimmermann M, Herdegen T.

Brain Res Mol Brain Res. 1997 Aug;48(1):7-16.

PMID:
9379852
41.

The missing link: adding assisted living to your existing services.

Brecht SB.

J Long Term Care Adm. 1996 Fall;24(3):4-6. No abstract available.

PMID:
10164258
42.

Isolation and characterization of genetically engineered gallidermin and epidermin analogs.

Ottenwälder B, Kupke T, Brecht S, Gnau V, Metzger J, Jung G, Götz F.

Appl Environ Microbiol. 1995 Nov;61(11):3894-903.

43.
44.

The transcription factor CREB is not phosphorylated at serine 133 in axotomized neurons: implications for the expression of AP-1 proteins.

Herdegen T, Gass P, Brecht S, Neiss WF, Schmid W.

Brain Res Mol Brain Res. 1994 Oct;26(1-2):259-70.

PMID:
7854055
45.

Induction of c-Jun and suppression of CREB transcription factor proteins in axotomized neurons of substantia nigra and covariation with tyrosine hydroxylase.

Brecht S, Gass P, Anton F, Bravo R, Zimmermann M, Herdegen T.

Mol Cell Neurosci. 1994 Oct;5(5):431-41.

PMID:
7820366
46.

Long-lasting expression of JUN and KROX transcription factors and nitric oxide synthase in intrinsic neurons of the rat brain following axotomy.

Herdegen T, Brecht S, Mayer B, Leah J, Kummer W, Bravo R, Zimmermann M.

J Neurosci. 1993 Oct;13(10):4130-45.

47.

Lender interest in LTC analyzed.

Brecht S, Turner R, Yulish M.

Contemp Longterm Care. 1990 Apr;13(4):41-2. No abstract available.

PMID:
10113161
48.

[Enflurane anaesthesia for epileptic patients (author's transl)].

Opitz A, Brecht S, Stenzel E.

Anaesthesist. 1977 Jul;26(7):329-32. German.

PMID:
889066

Supplemental Content

Loading ...
Support Center